Get started

Tilray

Tilray to $260+ by end of 2018 TLRY LongThe ascending triangle is most often a continuation pattern, so we should expect a bullish break to US $260 by the end of the year if the pattern plays out. This is support by Tilray's plans for global expansion and the decision today to legalise recreational use of marijuana in Canada. Recently the Tilray price has dropped despite a lot of good news for the marijuana industry in Canada. I believe this is because of lot of people are profit taking at these levels as they invested a while back when the price of Tilray (TLRY) was much lower.
NASDAQ:TLRYLong
by James_Winsoar
TILRAY - Tecnical AnalysisDear Traders, After TILRAY's crazy 92% run, it was time for it to retrace, and it did. Now that TILRAY has found support at the 0.382 fib level, we need to think. There are 2 possibilities here, or we retrace down to the 200 ema (which would be logic), or we have found enough support at this fib level to start building up again. I drew a green line marking a resistance line, and TLRY needs to breakout of it before turning bullish again. A good entry would be the 200 ema on the 1hr chart. What are your thoughts ?
NASDAQ:TLRY
by Raw_Blitz
TILRAY - Technical AnalysisDear Traders, We can see that TLRY has broken out but without big volume (which I expect, to be honest). I think most Traders/Bots are waiting for the MACD to cross upwards signal before creating another run-up. Let's see how this plays out. If you enter, don't forget your stop loss. About TILRAY: Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. Its products include dried cannabis and cannabis extracts. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada. Latest news: www.fool.com
NASDAQ:TLRYLong
by Raw_Blitz
TLRY - Pump, Dump, RepeatTilray's recent bubble pop has a lot of shareholders in panic mode. Despite the massive spread and a 60% drop from the high in just two days, an incredible amount of speculation still remains in the cannabis sector. What makes TLRY different than other cannabis stocks is the incredibly low float of ~18M shares, which serves to amplify the effects of speculative trading (in both directions). Compare the float to the average daily volume of 9M shares, and you will see what I mean. TLRY touched the 38.2% fib level after market Friday, and according to the 5/26 MACD has some room left to drop. I set my fibonacci bounds to the high near $300, and low at listing price around $20. It is difficult to tell how far down something this volatile will go, but according to the setup we can expect a bounce around the $60-$80 price range (likewise, when the 26-EMA touches $100, a previous support/resistance level). There will likely be a mini-bounce around $100 but I do not count on it sticking. 5/26 MACD indicates we have at least a few days before this thing will start to find a bottom. Implied volatility will be crushed as standard deviation reduces from the averaging of pump and dump outliers, which will in turn lower option premiums. Planning to buy some covered calls if the setup bites, otherwise reassessment will be necessary. Worst case scenario for this setup is that it hits the $60-$80 range and flattens, crushing option premium even further (which can be mitigated through use of covered calls combined with put credit spreads if necessary). Recreational legalization in Canada on Oct. 17th along with TLRY being the first Canadian cannabis company to obtain operational license within the U.S. add fuel to the fire that is speculation. Also of note is the disruptive impact that cannabis companies will have on traditional pharmaceuticals, a market holding ~$1.1T capitalization. There is also the potential for more states to legalize cannabis for either recreational/medical use. These all fuel speculative interactions within the market. A note on long term TLRY trades: there are 10M+ shares in lockup until January 2019, which will become public sometime then. I do not suggest holding any positions into January as the market will likely react violently to the increase in float.
NASDAQ:TLRYLong
by Derivati_Capital
5
Short on CRON - Divergence Technicals - CRON 9.78% broke out of a strong resistance today but failed to hold. Price is back within the parallel channel . In addition, RSI is diverging from price action. These are really simple, but strong bearish signals. Fundamentals - Following the success of Tilray 38.12% , CRON 9.78% soared two days in a row, breaking new highs. However, no significant fundamental news within the company justifies such a jump in prices. I believe that the 560% change in price in 52 weeks is clearly an overreaction and could lead to a massive dump. Institutional investors are massively short on Cannabis stocks in general; CRON 9.78% is overpriced and will drop back down to the $9.13-10 level.
NASDAQ:CRONShort
by Tutur
5